Designing Better Pediatric Medicines: Strategies to meet patient needs and regulatory expectations in the development of acceptable age-appropriate dosage forms
London, United Kingdom | 18 March 2026
Overview
Join us for a full-day event dedicated to advancing pediatric medicine, featuring expert-led sessions and networking opportunities.
Hosted by the Quotient Sciences team, this event brings together leading professionals to discuss key topics in pediatric drug development, including taste and palatability assessments, regulatory considerations, food compatibility, formulation development, and patient acceptability.
The agenda includes presentations from renowned speakers, interactive Q&A sessions, and ample time for networking over lunch and a drinks reception. Whether you’re looking to deepen your expertise, connect with peers, or explore the latest innovations in pediatric science, this event promises valuable insights and engaging discussions.
- Key learning objectives
- Taste and palatability assessment approaches for pediatric dosage forms
- Regulatory perspectives on PIP/PSP, pediatric QTPP, and excipient risk assessment
- Pediatric biopharmaceutics considerations
- Food compatibility in pediatric studies
- Formulation development pathways for pediatric products
- Patientcentric design and acceptability in hospital settings
| Time | Description |
|---|---|
| 09:00 AM - 5:00 PM | Duration |
| 09:00 AM – 09:15 AM | Welcome & Introduction - Nazim Kanji |
| 09:15 AM – 10:00 AM | Jenny Walsh (Jenny Walsh Consulting) Topics: Pediatric Quality Target Product Profiles Q&A |
| 10:00 AM – 10:45 AM | Kingsley Iyoha (Quotient) Topic: Pediatric Formulation Development and Clinical Assessment Q&A |
| 10:45 AM – 11:00 AM | Coffee Break |
| 11:00 AM – 11:45 AM | Enosh Mwesigwa (Azelis Pharma and Healthcare) Topic: Flavour Masking of Pediatric Formulations Q&A |
| 11:45 AM – 12:30 PM | Catherine Tuleu (UCL) Topic: Taste/Palatability Assessments Q&A |
| 12:30 PM – 13.15 PM | Justin Holland (Quotient) Topic: Food Compatibility Studies Q&A |
| 13.15 PM – 2:00 PM | Lunch & Networking |
| 2:00 PM – 2.45 PM | Louise Bracken (Alder Hey Children’s Hospital) Topics:Patient Considerations for Pediatric Dosage Form Design(TBC) Pediatric Acceptability Q&A |
| 2:45 PM – 3.30 PM | Hannah Batchelor (Strathclyde University) Topic: Pediatric Biopharmaceutics Q&A |
| 3.30 PM – 5:00 PM | Drinks reception | Closing Remarks Open floor for questions |
Register
Location
Royal Society of Chemistry
Burlington House, Piccadilly, W1J 0BA
London, United Kingdom